Correlation analysis of the alternative splicing events of CD44 with expression levels of CELF1 and ELAVL1 based on RNA-Seq data from TCGA revealed that high expression of CELF1 and/or ELAVL1 is correlated with the inclusion of CD44 variable exons in eight tumor types. The gene discussed is CD44; the disease is neoplasm.